Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demylelinating polyneuropathy
- 1 January 1998
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 43 (1) , 72-78
- https://doi.org/10.1002/ana.410430113
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- IgM anti-GM1 antibodies in the Guillain–Barré syndrome: a serological predictor of the clinical courseJournal of Neuroimmunology, 1997
- Reliability of isokinetic measurements of ankle dorsal and plantar flexors in normal subjects and in patients with peripheral neuropathyArchives of Physical Medicine and Rehabilitation, 1996
- Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg)Journal of Neuroimmunology, 1994
- Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathyMuscle & Nerve, 1994
- Do GM1 antibodies induce demyelination?Muscle & Nerve, 1994
- Multifocal motor neuropathy: Response to human immune globulinAnnals of Neurology, 1993
- Immunosuppressive treatment in multifocal motor neuropathyAnnals of Neurology, 1991
- Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of RanvierActa Neuropathologica, 1991
- Measurement and significance of antibodies against GM1 ganglioside Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.Journal of Neuroimmunology, 1989
- Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxinActa Neuropathologica, 1986